A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors
一项针对晚期实体瘤患者的utomilumab(PF-05082566)联合mogamulizumab的Ib期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/s40425-019-0815-6
Cohen, Ezra E W; Pishvaian, Michael J; Shepard, Dale R; Wang, Ding; Weiss, Jared; Johnson, Melissa L; Chung, Christine H; Chen, Ying; Huang, Bo; Davis, Craig B; Toffalorio, Francesca; Thall, Aron; Powell, Steven F